T‐ and L‐Type Voltage‐Gated Calcium Channels: Their Role in Diabetic Bladder Dysfunction. Issue 1 (12th March 2013)
- Record Type:
- Journal Article
- Title:
- T‐ and L‐Type Voltage‐Gated Calcium Channels: Their Role in Diabetic Bladder Dysfunction. Issue 1 (12th March 2013)
- Main Title:
- T‐ and L‐Type Voltage‐Gated Calcium Channels: Their Role in Diabetic Bladder Dysfunction
- Authors:
- Jiang, Xiaogang
Luttrell, Ian
Chitaley, Kanchan
Yang, Claire C. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="nau22391-sec-0001" sec-type="section"> <title>Aims</title> <p>We investigated the mechanisms of diabetic bladder dysfunction (BD) through analysis of the roles of L‐ and T‐type voltage‐gated calcium channels (VGCCs), with the ultimate goal of identifying potential drug targets for diabetic BD.</p> </sec> <sec id="nau22391-sec-0002" sec-type="section"> <title>Methods</title> <p>Bladder function of <italic>db/db</italic> (type 2 diabetes) and wild type (<italic>Wt</italic>) mice was evaluated by behavioral tests and in vivo cystometry. Contractile responses of bladder strips to carbachol were measured with or without pre‐treatment with nifedipine (a L‐type VGCC blocker) or mibefradil (a T‐type VGCC blocker). Furthermore, the effects of mibefradil and nifedipine on the proliferation of human bladder smooth muscle cells (BSMCs) were studied.</p> </sec> <sec id="nau22391-sec-0003" sec-type="section"> <title>Results</title> <p> <italic>db/db</italic> mice had significantly increased voiding frequency, bladder weight, bladder compliance and capacity, and heightened contractile response to carbachol, compared to <italic>Wt</italic> mice. Nifedipine, but not mibefradil, dramatically suppressed bladder tissue contraction in <italic>Wt</italic> mice. Whereas nifedipine nearly completely inhibited bladder contraction in <italic>db/db</italic> mice, mibefradil "normalized" the heightened bladder contractility<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="nau22391-sec-0001" sec-type="section"> <title>Aims</title> <p>We investigated the mechanisms of diabetic bladder dysfunction (BD) through analysis of the roles of L‐ and T‐type voltage‐gated calcium channels (VGCCs), with the ultimate goal of identifying potential drug targets for diabetic BD.</p> </sec> <sec id="nau22391-sec-0002" sec-type="section"> <title>Methods</title> <p>Bladder function of <italic>db/db</italic> (type 2 diabetes) and wild type (<italic>Wt</italic>) mice was evaluated by behavioral tests and in vivo cystometry. Contractile responses of bladder strips to carbachol were measured with or without pre‐treatment with nifedipine (a L‐type VGCC blocker) or mibefradil (a T‐type VGCC blocker). Furthermore, the effects of mibefradil and nifedipine on the proliferation of human bladder smooth muscle cells (BSMCs) were studied.</p> </sec> <sec id="nau22391-sec-0003" sec-type="section"> <title>Results</title> <p> <italic>db/db</italic> mice had significantly increased voiding frequency, bladder weight, bladder compliance and capacity, and heightened contractile response to carbachol, compared to <italic>Wt</italic> mice. Nifedipine, but not mibefradil, dramatically suppressed bladder tissue contraction in <italic>Wt</italic> mice. Whereas nifedipine nearly completely inhibited bladder contraction in <italic>db/db</italic> mice, mibefradil "normalized" the heightened bladder contractility of <italic>db/db</italic> mice to the level of <italic>Wt</italic> mice. In culture, mibefradil, but not nifedipine, inhibited the proliferation of human BSMCs.</p> </sec> <sec id="nau22391-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Our results indicate that while L‐type VGCCs play a major role in the contraction of both diabetic and non‐diabetic bladders, T‐type VGCCs are involved in the contraction of diabetic bladders and mediate BSMC proliferation. This study provides support for further investigations on the effect of blockade of T‐type VGCC or combined blockade of both types of VGCCs in the treatment of diabetic BD. <italic>Neurourol. Urodynam. 33:147–152, 2014</italic>. © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Neurourology and urodynamics. Volume 33:Issue 1(2014:Jan.)
- Journal:
- Neurourology and urodynamics
- Issue:
- Volume 33:Issue 1(2014:Jan.)
- Issue Display:
- Volume 33, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 33
- Issue:
- 1
- Issue Sort Value:
- 2014-0033-0001-0000
- Page Start:
- 147
- Page End:
- 152
- Publication Date:
- 2013-03-12
- Subjects:
- Urinary organs -- Periodicals
Urodynamics -- Periodicals
Urology -- Periodicals
616.6 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-6777 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/nau.22391 ↗
- Languages:
- English
- ISSNs:
- 0733-2467
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.589000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4105.xml